T&L Co (340570.KQ) Stock Price

T&L Co Price

CLOSED
23,850.00
​
Market closed

Revenue has compounded at 25.6% per year over the past 8 years to 164.16 B KRW. Earnings per share have grown at 15.5% per year over the last 8 years. T&L Co's net margin stands at 23.2%, down from 27.2% several years earlier. T&L Co currently offers a dividend yield of about 3.14%. The payout ratio is around 32% of earnings. The dividend has grown at 49.6% per year over the past 5 years. Analysts set a median price target of 81,600.00 KRW, implying 242.1% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

T&L Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

T&L Co business model & stock analysis

T&L Co., Ltd. generates revenue through the sale of medical polymer material products including wound treatment materials like hydrocolloids, foams, and hydrogels, which are essential for wound healing. The company also offers orthopedic fixing materials such as casts and splints for fracture treatment, alongside structural adhesives and water repellents. Domestic and international markets, particularly the United States, Germany, China, and Dubai, purchase these products. The firm's product portfolio targets healthcare providers and medical facilities requiring specialized materials for patient care. T&L Co., Ltd. focuses on developing medical polymer materials that serve specific clinical needs, with wound treatment materials being a key segment. Orthopedic fixing materials are sold to hospitals and clinics for fracture management, while structural adhesives and water repellents cater to industrial applications. The company's international presence in the United States, Germany, China, and Dubai supports its market diversification strategy. The firm's revenue streams are derived from the consistent demand for medical polymer products in wound care, orthopedic solutions, and industrial adhesives. Products such as hydrocolloids, foams, and hydrogels are sold to healthcare providers, while orthopedic devices like casts and splints are distributed to medical institutions. Structural adhesives and water repellents are marketed to industrial clients in key global markets.

Frequently asked questions about T&L Co

Analysts currently set an average price target of 81,600.00 KRW for the T&L Co stock (median: 81,600.00 KRW), implying +242.1 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the T&L Co stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect T&L Co to generate revenue of 187.30 B KRW and earnings per share of 1,784.88 KRW.

Converted at the current exchange rate, the T&L Co share trades at 15.88 EUR (23,850.00 KRW).

The expected revenue of T&L Co is 187.30 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of T&L Co is 28.62 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of T&L Co is currently 13.36. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the T&L Co stock.

The price-to-sales ratio (P/S) of T&L Co is currently 2.04. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the T&L Co stock.

The Eulerpool Quality Score for T&L Co is 7/10.

The ISIN of T&L Co is KR7340570001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of T&L Co is 340570.KQ. The ticker symbol is used to trade T&L Co shares on the stock exchange.

Fair ValueTerminal
24,327.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website tnl.co.kr
Country
South Korea
Currency
KRW
Initial public offering
Nov 20, 2020
ISIN
KR7340570001
Cusip
Y8T4FG105
Market capitalization
192.52 B KRWLarge Cap
52-Week Range
PEG
1.55
P/E ratio
P/Ee 2026
6.73
P/Ee 2027
6.46
P/Ee 2028
5.57
P/S
P/Se
2.04
EV/EBIT
4.15
P/B Ratio
0.96
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
18.93 %
Dividend
Dividend yield
3.14 %
Est. Dividend Yield
3.77 %
Payout Ratio
31.58 %
Dividend growth Ø5Y
30.26 %
Dividend payments per year
1
Dividend paid since
6 years
Dividend not reduced since
6 years
Dividend increased since
6 years
Dividend withholding tax
22.00 %
Last updated Nov 11, 2026, 9:08 PM

T&L Co Peer Group

T&L Co FIGI

340570:KS · BBG001V489P9340570:KQ · BBG00XKYFRH6

All fundamentals and in-depth analysis of T&L Co

Our stock analysis for T&L Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of T&L Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.